Purchases and Sales Made in Q3 2022 in Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC) during Q3 2022. The information is specifically focused on institutions that hold shares of Oric Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-40.1K- 12.35% |
$126K - $210K
|
284K
$2.27M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-41.5K- 52.41% |
$131K - $218K
|
37.7K
$302K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-46.5K- 10.38% |
$146K - $243K
|
401K
$3.21M
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-60.6K- 75.22% |
$191K - $318K
|
20K
$160K
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-61.3K- 26.04% |
$193K - $321K
|
174K
$1.39M
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-66.9K- 4.73% |
$211K - $350K
|
1.35M
$10.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-69.3K- 45.24% |
$218K - $363K
|
83.8K
$671K
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-96.2K- 36.38% |
$303K - $504K
|
168K
$1.35M
|
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-128K- 88.46% |
$402K - $669K
|
16.7K
$133K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-188K- 93.79% |
$592K - $985K
|
12.4K
$99.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-739K- 57.62% |
$2.33M - $3.87M
|
544K
$4.35M
|